Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome

[1]  Shuli Wang,et al.  Hepatic Overexpression of Glycerol-sn-3-phosphate Acyltransferase 1 in Rats Causes Insulin Resistance* , 2007, Journal of Biological Chemistry.

[2]  M. Birnbaum,et al.  Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. , 2007, Cell metabolism.

[3]  K. Petersen,et al.  Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction , 2006, Diabetes.

[4]  S. Kahn,et al.  Review: The role of insulin resistance in nonalcoholic fatty liver disease. , 2006, The Journal of clinical endocrinology and metabolism.

[5]  A. Häkkinen,et al.  Overproduction of large VLDL particles is driven by increased liver fat content in man , 2006, Diabetologia.

[6]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[7]  T. Kadowaki,et al.  Adiponectin and adiponectin receptors. , 2005, Endocrine reviews.

[8]  E. Ferrannini,et al.  Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms , 2005, Diabetologia.

[9]  B. Goodpaster,et al.  Exercise training increases intramyocellular lipid and oxidative capacity in older adults. , 2004, American journal of physiology. Endocrinology and metabolism.

[10]  F. Schick,et al.  Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. , 2003, The Journal of clinical endocrinology and metabolism.

[11]  A. Häkkinen,et al.  Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. , 2001, Diabetes.

[12]  G. Marchesini,et al.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.

[13]  N. Laurin,et al.  The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. , 2001, Obesity research.

[14]  A. Häkkinen,et al.  Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. , 2000, Diabetes.

[15]  C Boesch,et al.  Observation of Intramyocellular Lipids by1H‐Magnetic Resonance Spectroscopy , 2000, Annals of the New York Academy of Sciences.

[16]  Simon C Watkins,et al.  Intramuscular lipid content is increased in obesity and decreased by weight loss. , 2000, Metabolism: clinical and experimental.

[17]  D L Rothman,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Intramuscular Glycogen and Intramyocellular Lipid Utilization during Prolonged Exercise and Recovery in Man: A 13 C and 1 H Nuclear Magnetic Res , 1999 .

[18]  F. Schick,et al.  Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. , 1999, Diabetes.

[19]  F. Schick,et al.  Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. , 1999, American journal of physiology. Endocrinology and metabolism.

[20]  A Mari,et al.  How to measure insulin sensitivity , 1998, Journal of hypertension.

[21]  M. Taskinen,et al.  Metabolic basis of hypotriglyceridemic effects of insulin in normal men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[22]  S. Lillioja,et al.  Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action , 1997, Diabetes.

[23]  M. Taskinen,et al.  Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM , 1997, Diabetologia.

[24]  Yki-Järvinen Hannele.  3 Action of insulin on glucose metabolism in vivo , 1993 .

[25]  F Schick,et al.  Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: Two lipid compartments in muscle tissue , 1993, Magnetic resonance in medicine.

[26]  A. Goldberg,et al.  Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age. , 1992, The Journal of clinical endocrinology and metabolism.

[27]  H. Yki-Järvinen,et al.  No Reduction in Total Hepatic Glucose Output by Inhibition of Gluconeogenesis With Ethanol in NIDDM Patients , 1991, Diabetes.

[28]  V. Salomaa,et al.  Body fat distribution in the Finnish population: environmental determinants and predictive power for cardiovascular risk factor levels. , 1991, Journal of epidemiology and community health.

[29]  G. Reaven.  Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[30]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[31]  H. Yki-Järvinen,et al.  Kinetics of glucose disposal in whole body and across the forearm in man. , 1987, The Journal of clinical investigation.

[32]  G. Dalsky,et al.  Muscle triglyceride utilization during exercise: effect of training. , 1986, Journal of applied physiology.

[33]  H C Lukaski,et al.  Assessment of fat-free mass using bioelectrical impedance measurements of the human body. , 1985, The American journal of clinical nutrition.

[34]  H. Yki-Järvinen,et al.  Effects of Body Composition on Insulin Sensitivity , 1983, Diabetes.

[35]  R. DeFronzo,et al.  The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization , 1981, Diabetes.

[36]  L. Mandarino,et al.  Dose-response characteristics for effects of insulin on production and utilization of glucose in man. , 1981, The American journal of physiology.

[37]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[38]  D L Horwitz,et al.  Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.

[39]  J. Sternberg,et al.  A New and Rapid Method for the Determination of Glucose by Measurement of Rate of Oxygen Consumption , 1968 .

[40]  R. Steele,et al.  INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.

[41]  S. Summers,et al.  Ceramides in insulin resistance and lipotoxicity. , 2006, Progress in lipid research.

[42]  B. Goodpaster,et al.  Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state , 2005, Pflügers Archiv.

[43]  L. DiPietro,et al.  Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.

[44]  G. Reaven.  Banting lecture 1988 , 1997 .

[45]  C. Thomsen,et al.  Quantification of liver fat using magnetic resonance spectroscopy. , 1994, Magnetic resonance imaging.

[46]  H. Yki-Järvinen.  Action of insulin on glucose metabolism in vivo. , 1993, Bailliere's clinical endocrinology and metabolism.

[47]  J. Aikens,et al.  A microfluorometric method for the determination of free fatty acids in plasma. , 1983, Journal of lipid research.

[48]  A. Häkkinen,et al.  Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. , 2002, The Journal of clinical endocrinology and metabolism.